American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

Cites (1,959)

Items 201–400 of 1,861

1. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
   Agarwal, Rajiv, Filippatos, Gerasimos, Pitt, Bertram, Anker, Stefan D, Rossing, Peter, Joseph, Amer, Kolkhof, Peter, Nowack, Christina, Gebel, Martin, Ruilope, Luis M et al. · 2022 · European Heart Journal
2. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria
   1999 · The Lancet
3. Effects of medical therapies on retinopathy progression in type 2 diabetes
   The ACCORD Study Group and ACCORD Eye Study Group · 2010 · New England Journal of Medicine
4. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
   Williams, Bryan, MacDonald, Thomas M, Morant, Steve, Webb, David J, Sever, Peter, McInnes, Gordon, Ford, Ian, Cruickshank, J Kennedy, Caulfield, Mark J, Salsbury, Jackie et al. · 2015 · The Lancet
5. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut‐off points of body mass index and waist circumference in Chinese adults
   Zhou Bei‐Fan, the Cooperative Meta‐analysis Group of Working Group on Obesity in China · 2002 · Asia Pacific Journal of Clinical Nutrition
6. Prevention and management of type 2 diabetes: dietary components and nutritional strategies
   Ley, Sylvia H, Hamdy, Osama, Mohan, Viswanathan, Hu, Frank B · 2014 · The Lancet
7. Metformin versus insulin for the treatment of gestational diabetes
   Rowan, Janet A., Hague, William M., Gao, Wanzhen, Battin, Malcolm R., Moore, M. Peter · 2008 · New England Journal of Medicine
8. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: A study of discordant sibships
   Dabelea, D, Hanson, R L, Lindsay, R S, Pettitt, D J, Imperatore, G, Gabir, M M, Roumain, J, Bennett, P H, Knowler, W C · 2000 · Diabetes
9. Prevalence of the metabolic syndrome in the United States, 2003-2012
   Aguilar, Maria, Bhuket, Taft, Torres, Sharon, Liu, Benny, Wong, Robert J. · 2015 · JAMA
10. Liraglutide and renal outcomes in type 2 diabetes
    Mann, Johannes F.E., Ørsted, David D., Brown-Frandsen, Kirstine, Marso, Steven P., Poulter, Neil R., Rasmussen, Søren, Tornøe, Karen, Zinman, Bernard, Buse, John B. · 2017 · New England Journal of Medicine
11. Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Micha, Renata, Wallace, Sarah K., Mozaffarian, Dariush · 2010 · Circulation
12. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
    McGuire, Darren K., Shih, Weichung J., Cosentino, Francesco, Charbonnel, Bernard, Cherney, David Z. I., Dagogo-Jack, Samuel, Pratley, Richard, Greenberg, Michelle, Wang, Shuai, Huyck, Susan et al. · 2021 · JAMA Cardiology
13. Untitled work
    1964 · PubMed
14. Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
    Insel, Richard A., Dunne, Jessica L., Atkinson, Mark A., Chiang, Jane L., Dabelea, Dana, Gottlieb, Peter A., Greenbaum, Carla J., Herold, Kevan C., Krischer, Jeffrey P., Lernmark, Åke et al. · 2015 · Diabetes Care
15. Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
    Gress, Todd W., Nieto, F. Javier, Shahar, Eyal, Wofford, Marion R., Brancati, Frederick L. · 2000 · New England Journal of Medicine
16. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial
    Davies, Melanie J., Bergenstal, Richard, Bode, Bruce, Kushner, Robert F., Lewin, Andrew, Skjøth, Trine Vang, Andreasen, Arne Haahr, Jensen, Christine Bjørn, DeFronzo, Ralph A., for the NN8022-1922 Study Group · 2015 · JAMA
17. 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Buse, John B., Wexler, Deborah J., Tsapas, Apostolos, Rossing, Peter, Mingrone, Geltrude, Mathieu, Chantal, D’Alessio, David A., Davies, Melanie J. · 2020 · Diabetes Care
18. A general cardiovascular risk profile: The Framingham study
    Kannel, William B., McGee, Daniel, Gordon, Tavia · 1976 · The American Journal of Cardiology
19. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
    Beck, Roy W., Riddlesworth, Tonya, Ruedy, Katrina, Ahmann, Andrew, Bergenstal, Richard, Haller, Stacie, Kollman, Craig, Kruger, Davida, McGill, Janet B., Polonsky, William et al. · 2017 · JAMA
20. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update
    Camacho, Pauline M., Petak, Steven M., Binkley, Neil, Diab, Dima L., Eldeiry, Leslie S., Farooki, Azeez, Harris, Steven T., Hurley, Daniel L., Kelly, Jennifer, Lewiecki, E. Michael et al. · 2020 · Endocrine Practice
21. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
    Kendall, David M., Riddle, Matthew C., Rosenstock, Julio, Zhuang, Dongliang, Kim, Dennis D., Fineman, Mark S., Baron, Alain D. · 2005 · Diabetes Care
22. Combined angiotensin inhibition for the treatment of diabetic nephropathy
    Fried, Linda F., Emanuele, Nicholas, Zhang, Jane H., Brophy, Mary, Conner, Todd A., Duckworth, William, Leehey, David J., McCullough, Peter A., O'Connor, Theresa, Palevsky, Paul M. et al. · 2013 · New England Journal of Medicine
23. Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study
    Astrup, Arne, Rössner, Stephan, Van Gaal, Luc, Rissanen, Aila, Niskanen, Leo, Al Hakim, Mazin, Madsen, Jesper, Rasmussen, Mads F, Lean, Michael EJ · 2009 · The Lancet
24. Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus: Four-Year Results of the Look AHEAD Trial
    2010 · Archives of Internal Medicine
25. Hypoglycemia in Diabetes
    Cryer, Philip E., Davis, Stephen N., Shamoon, Harry · 2003 · Diabetes Care
26. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
    Eckel, Robert H., Jakicic, John M., Ard, Jamy D., de Jesus, Janet M., Houston Miller, Nancy, Hubbard, Van S., Lee, I-Min, Lichtenstein, Alice H., Loria, Catherine M., Millen, Barbara E. et al. · 2014 · Journal of the American College of Cardiology
27. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
    Carey, Robert M., Calhoun, David A., Bakris, George L., Brook, Robert D., Daugherty, Stacie L., Dennison-Himmelfarb, Cheryl R., Egan, Brent M., Flack, John M., Gidding, Samuel S., Judd, Eric et al. · 2018 · Hypertension
28. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
    Camacho, Pauline M., Petak, Steven M., Binkley, Neil, Clarke, Bart L., Harris, Steven T., Hurley, Daniel L., Kleerekoper, Michael, Lewiecki, E. Michael, Miller, Paul D., Narula, Harmeet S. et al. · 2016 · Endocrine Practice
29. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
    Furnary, Anthony P., Gao, Guangqiang, Grunkemeier, Gary L., Wu, YingXing, Zerr, Kathryn J., Bookin, Stephen O., Floten, H.Storm, Starr, Albert · 2003 · The Journal of Thoracic and Cardiovascular Surgery
30. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
    Kernan, Walter N., Viscoli, Catherine M., Furie, Karen L., Young, Lawrence H., Inzucchi, Silvio E., Gorman, Mark, Guarino, Peter D., Lovejoy, Anne M., Peduzzi, Peter N., Conwit, Robin et al. · 2016 · New England Journal of Medicine
31. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline
    Umpierrez, Guillermo E., Hellman, Richard, Korytkowski, Mary T., Kosiborod, Mikhail, Maynard, Gregory A., Montori, Victor M., Seley, Jane J., Van den Berghe, Greet · 2012 · The Journal of Clinical Endocrinology & Metabolism
32. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
    Wadden, Thomas A., Bailey, Timothy S., Billings, Liana K., Davies, Melanie, Frias, Juan P., Koroleva, Anna, Lingvay, Ildiko, O’Neil, Patrick M., Rubino, Domenica M., Skovgaard, Dorthe et al. · 2021 · JAMA
33. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study
    Norhammar, Anna, Tenerz, Åke, Nilsson, Göran, Hamsten, Anders, Efendíc, Suad, Rydén, Lars, Malmberg, Klas · 2002 · The Lancet
34. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
    Keech, AC, Mitchell, P, Summanen, PA, O'Day, J, Davis, TME, Moffitt, MS, Taskinen, M-R, Simes, RJ, Tse, D, Williamson, E et al. · 2007 · The Lancet
35. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
    Huxley, R, Ansary-Moghaddam, A, Berrington de González, A, Barzi, F, Woodward, M · 2005 · British Journal of Cancer
36. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data
    Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S. et al. · 2009 · Canadian Medical Association Journal
37. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease
    Jellinger, Paul S., Handelsman, Yehuda, Rosenblit, Paul D., Bloomgarden, Zachary T., Fonseca, Vivian A., Garber, Alan J., Grunberger, George, Guerin, Chris K., Bell, David S.H., Mechanick, Jeffrey I. et al. · 2017 · Endocrine Practice
38. Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
    Hans‐Henrik Parving, Frederik Persson, Julia Breyer Lewis, Edmund J. Lewis, Norman K. Hollenberg · 2008 · New England Journal of Medicine
39. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
    Gadde, Kishore M, Allison, David B, Ryan, Donna H, Peterson, Craig A, Troupin, Barbara, Schwiers, Michael L, Day, Wesley W · 2011 · The Lancet
40. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
    Garber, Alan, Henry, Robert, Ratner, Robert, Garcia-Hernandez, Pedro A, Rodriguez-Pattzi, Hiromi, Olvera-Alvarez, Israel, Hale, Paula M, Zdravkovic, Milan, Bode, Bruce · 2009 · The Lancet
41. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications
    Sjöström, Lars, Peltonen, Markku, Jacobson, Peter, Ahlin, Sofie, Andersson-Assarsson, Johanna, Anveden, Åsa, Bouchard, Claude, Carlsson, Björn, Karason, Kristjan, Lönroth, Hans et al. · 2014 · JAMA
42. Temporal trends in the prevalence of diabetic kidney disease in the United States
    de Boer, Ian H. · 2011 · JAMA
43. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Greenway, Frank L, Fujioka, Ken, Plodkowski, Raymond A, Mudaliar, Sunder, Guttadauria, Maria, Erickson, Janelle, Kim, Dennis D, Dunayevich, Eduardo · 2010 · The Lancet
44. Long-term effects of intensive glucose lowering on cardiovascular outcomes
    The ACCORD Study Group · 2011 · New England Journal of Medicine
45. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
    Brown, Sue A., Kovatchev, Boris P., Raghinaru, Dan, Lum, John W., Buckingham, Bruce A., Kudva, Yogish C., Laffel, Lori M., Levy, Carol J., Pinsker, Jordan E., Wadwa, R. Paul et al. · 2019 · New England Journal of Medicine
46. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
    2015 · The Lancet Diabetes & Endocrinology
47. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial
    Cusi, Kenneth, Orsak, Beverly, Bril, Fernando, Lomonaco, Romina, Hecht, Joan, Ortiz-Lopez, Carolina, Tio, Fermin, Hardies, Jean, Darland, Celia, Musi, Nicolas et al. · 2016 · Annals of Internal Medicine
48. Diet Quality as Assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension Score, and Health Outcomes: A Systematic Review and Meta-Analysis of Cohort Studies
    Schwingshackl, Lukas, Hoffmann, Georg · 2015 · Journal of the Academy of Nutrition and Dietetics
49. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
    Cusi, Kenneth, Isaacs, Scott, Barb, Diana, Basu, Rita, Caprio, Sonia, Garvey, W. Timothy, Kashyap, Sangeeta, Mechanick, Jeffrey I., Mouzaki, Marialena, Nadolsky, Karl et al. · 2022 · Endocrine Practice
50. UKPDS 50: Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis
    Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., Matthews, D. R. · 2001 · Diabetologia
51. Hypoglycemia and risk of death in critically ill patients
    The NICE-SUGAR Study Investigators · 2012 · New England Journal of Medicine
52. Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension
    Weber, Michael A., Schiffrin, Ernesto L., White, William B., Mann, Samuel, Lindholm, Lars H., Kenerson, John G., Flack, John M., Carter, Barry L., Materson, Barry J., Ram, C. Venkata S. et al. · 2014 · The Journal of Clinical Hypertension
53. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
    Lean, Michael E J, Leslie, Wilma S, Barnes, Alison C, Brosnahan, Naomi, Thom, George, McCombie, Louise, Peters, Carl, Zhyzhneuskaya, Sviatlana, Al-Mrabeh, Ahmad, Hollingsworth, Kieren G et al. · 2019 · The Lancet Diabetes & Endocrinology
54. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms
    Jensen, Troels S, Finnerup, Nanna B · 2014 · The Lancet Neurology
55. Association of Hemoglobin A _1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk
    Khaw, Kay-Tee, Wareham, Nicholas, Bingham, Sheila, Luben, Robert, Welch, Ailsa, Day, Nicholas · 2004 · Annals of Internal Medicine
56. Diabetic Retinopathy: A Position Statement by the American Diabetes Association
    Sharon D. Solomon, Emily Y. Chew, Elia J. Duh, Lucia Sobrin, Jennifer K. Sun, Brian L. VanderBeek, Charles C. Wykoff, Thomas W. Gardner · 2017 · Diabetes Care
57. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
    Spallone, Vincenza, Ziegler, Dan, Freeman, Roy, Bernardi, Luciano, Frontoni, Simona, Pop‐Busui, Rodica, Stevens, Martin, Kempler, Peter, Hilsted, Jannik, Tesfaye, Solomon et al. · 2011 · Diabetes/Metabolism Research and Reviews
58. Effects of Aerobic and Resistance Training on Hemoglobin A _1c Levels in Patients With Type 2 Diabetes: A Randomized Controlled Trial
    Church, Timothy S., Blair, Steven N., Cocreham, Shannon, Johannsen, Neil, Johnson, William, Kramer, Kimberly, Mikus, Catherine R., Myers, Valerie, Nauta, Melissa, Rodarte, Ruben Q. et al. · 2010 · JAMA
59. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
    The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group · 2002 · JAMA: The Journal of the American Medical Association
60. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study
    Bonds, D. E, Miller, M. E, Bergenstal, R. M, Buse, J. B, Byington, R. P, Cutler, J. A, Dudl, R J., Ismail-Beigi, F., Kimel, A. R, Hoogwerf, B. et al. · 2010 · BMJ
61. Untitled work
    Boulton · 2008 · 10.2337/dc08-9021
62. Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort Study
    Laaksonen, D. E. · 2002 · American Journal of Epidemiology
63. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial
    2002 · BMJ
64. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization guideline
    2014 · Diabetes Research and Clinical Practice
65. Walking Compared With Vigorous Physical Activity and Risk of Type 2 Diabetes in Women: A Prospective Study
    Hu, Frank B., Sigal, Ronald J., Rich-Edwards, Janet W., Colditz, Graham A., Solomon, Caren G., Willett, Walter C., Speizer, Frank E., Manson, JoAnn E. · 1999 · JAMA
66. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control
    Chrvala, Carole A., Sherr, Dawn, Lipman, Ruth D. · 2016 · Patient Education and Counseling
67. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base
    Feinman, Richard D., Pogozelski, Wendy K., Astrup, Arne, Bernstein, Richard K., Fine, Eugene J., Westman, Eric C., Accurso, Anthony, Frassetto, Lynda, Gower, Barbara A., McFarlane, Samy I. et al. · 2015 · Nutrition
68. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
    Preiser, Jean-Charles, Devos, Philippe, Ruiz-Santana, Sergio, Mélot, Christian, Annane, Djillali, Groeneveld, Johan, Iapichino, Gaetano, Leverve, Xavier, Nitenberg, Gérard, Singer, Pierre et al. · 2009 · Intensive Care Medicine
69. Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
    Salas-Salvadó, Jordi, Bulló, Monica, Babio, Nancy, Martínez-González, Miguel Ángel, Ibarrola-Jurado, Núria, Basora, Josep, Estruch, Ramon, Covas, Maria Isabel, Corella, Dolores, Arós, Fernando et al. · 2011 · Diabetes Care
70. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    Neuen, Brendon L, Young, Tamara, Heerspink, Hiddo J L, Neal, Bruce, Perkovic, Vlado, Billot, Laurent, Mahaffey, Kenneth W, Charytan, David M, Wheeler, David C, Arnott, Clare et al. · 2019 · The Lancet Diabetes & Endocrinology
71. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
    Bolinder, Jan, Antuna, Ramiro, Geelhoed-Duijvestijn, Petronella, Kröger, Jens, Weitgasser, Raimund · 2016 · The Lancet
72. Diabetic dyslipidaemia: from basic research to clinical practice*
    Taskinen, M.-R. · 2003 · Diabetologia
73. Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
    Berglund, Lars, Brunzell, John D., Goldberg, Anne C., Goldberg, Ira J., Sacks, Frank, Murad, Mohammad Hassan, Stalenhoef, Anton F. H. · 2012 · The Journal of Clinical Endocrinology & Metabolism
74. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
    Currie, Craig J, Peters, John R, Tynan, Aodán, Evans, Marc, Heine, Robert J, Bracco, Oswaldo L, Zagar, Tony, Poole, Chris D · 2010 · The Lancet
75. 10. Cardiovascular Disease and Risk Management: <i>Standards of Medical Care in Diabetes—2022</i>
    American Diabetes Association Professional Practice Committee · 2022 · Diabetes Care
76. Predicting the 30-Year Risk of Cardiovascular Disease
    Michael J. Pencina, Ralph B. D’Agostino, Martin G. Larson, Joseph M. Massaro, Ramachandran Srini Vasan · 2009 · Circulation
77. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
    le Roux, Carel W, Astrup, Arne, Fujioka, Ken, Greenway, Frank, Lau, David C W, Van Gaal, Luc, Ortiz, Rafael Violante, Wilding, John P H, Skjøth, Trine V, Manning, Linda Shapiro et al. · 2017 · The Lancet
78. Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition
    Peters, Anne L., Buschur, Elizabeth O., Buse, John B., Cohan, Pejman, Diner, Jamie C., Hirsch, Irl B. · 2015 · Diabetes Care
79. Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
    Zinman, Bernard, Gerich, John, Buse, John B., Lewin, Andrew, Schwartz, Sherwyn, Raskin, Philip, Hale, Paula M., Zdravkovic, Milan, Blonde, Lawrence, the LEAD-4 Study Investigators · 2009 · Diabetes Care
80. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
    Richardson, Tom G., Sanderson, Eleanor, Palmer, Tom M., Ala-Korpela, Mika, Ference, Brian A., Davey Smith, George, Holmes, Michael V. · 2020 · PLOS Medicine
81. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance Randomized Study
    on behalf of the NN8022-1923 Investigators, Wadden, T A, Hollander, P, Klein, S, Niswender, K, Woo, V, Hale, P M, Aronne, L · 2013 · International Journal of Obesity
82. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men
    Ridker, Paul M, Paynter, Nina P., Rifai, Nader, Gaziano, J. Michael, Cook, Nancy R. · 2008 · Circulation
83. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    Goff, David C., Donald M. Lloyd‐Jones, Glen C. Bennett, Sean Coady, Ralph B. D’Agostino, Gibbons, Raymond, Greenland, Philip, Lackland, Daniel T., Daniel A Levy, Christopher J. O’Donnell et al. · 2014 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
84. Genetically elevated C-reactive protein and ischemic vascular disease
    Zacho, Jeppe, Tybjærg-Hansen, Anne, Jensen, Jan Skov, Grande, Peer, Sillesen, Henrik, Nordestgaard, Børge G. · 2008 · New England Journal of Medicine
85. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
    on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group, Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R. · 2009 · Diabetologia
86. Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
    Gerstein, Hertzel C., Sattar, Naveed, Rosenstock, Julio, Ramasundarahettige, Chinthanie, Pratley, Richard, Lopes, Renato D., Lam, Carolyn S.P., Khurmi, Nardev S., Heenan, Laura, Del Prato, Stefano et al. · 2021 · New England Journal of Medicine
87. Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
    UK Hypoglycaemia Study Group · 2007 · Diabetologia
88. The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic Evidence
    Hashem B. El‐Serag, Howard Hampel, Fariba Javadi · 2006 · Clinical Gastroenterology and Hepatology
89. Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus
    Shari Danielle Bolen, Leonard Samuel Feldman, Jason L. Vassy, Lisa M Wilson, Hsin‐Chieh Yeh, Spyridon S Marinopoulos, Crystal Wiley, Elizabeth Selvin, Renée F Wilson, Eric B Bass et al. · 2007 · Annals of Internal Medicine
90. Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)
    Michel Marre, Jonathan E. Shaw, Michael Brändle, Wan Mohamad Wan Bebakar, Nor Azmi Kamaruddin, Jorma Strand, Marija D. Zdravkovic, Tu D. L. Thi, Stephen Colagiuri, on behalf of the LEAD‐1 SU study group · 2009 · Diabetic Medicine
91. Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients
    Snowling, Neil J., Hopkins, Will G. · 2006 · Diabetes Care
92. Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
    Kosiborod, Mikhail, Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Birkeland, Kåre I., Jørgensen, Marit Eika, Thuresson, Marcus et al. · 2017 · Circulation
93. Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT): a multicentre international randomised controlled trial
    Feig, Denice S, Donovan, Lois E, Corcoy, Rosa, Murphy, Kellie E, Amiel, Stephanie A, Hunt, Katharine F, Asztalos, Elizabeth, Barrett, Jon F R, Sanchez, J Johanna, de Leiva, Alberto et al. · 2017 · The Lancet
94. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
    Carlsson, Lena M.S., Peltonen, Markku, Ahlin, Sofie, Anveden, Åsa, Bouchard, Claude, Carlsson, Björn, Jacobson, Peter, Lönroth, Hans, Maglio, Cristina, Näslund, Ingmar et al. · 2012 · New England Journal of Medicine
95. Renal and retinal effects of enalapril and losartan in type 1 diabetes
    Mauer, Michael, Zinman, Bernard, Gardiner, Robert, Suissa, Samy, Sinaiko, Alan, Strand, Trudy, Drummond, Keith, Donnelly, Sandra, Goodyer, Paul, Gubler, Marie Claire et al. · 2009 · New England Journal of Medicine
96. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care ^#
    Hod, Moshe, Kapur, Anil, Sacks, David A., Hadar, Eran, Agarwal, Mukesh, Di Renzo, Gian Carlo, Roura, Luis Cabero, McIntyre, Harold David, Morris, Jessica L., Divakar, Hema · 2015 · International Journal of Gynecology &amp; Obstetrics
97. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the united states
    Bode, Bruce, Garrett, Valerie, Messler, Jordan, McFarland, Raymie, Crowe, Jennifer, Booth, Robby, Klonoff, David C. · 2020 · Journal of Diabetes Science and Technology
98. Long-term follow-up after tight control of blood pressure in type 2 diabetes
    Holman, Rury R., Paul, Sanjoy K., Bethel, M. Angelyn, Neil, H. Andrew W., Matthews, David R. · 2008 · New England Journal of Medicine
99. Physical Activity of Moderate Intensity and Risk of Type 2 Diabetes
    Jeon, Christie Y., Lokken, R. Peter, Hu, Frank B., van Dam, Rob M. · 2007 · Diabetes Care
100. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
     Viney, Nicholas J, van Capelleveen, Julian C, Geary, Richard S, Xia, Shuting, Tami, Joseph A, Yu, Rosie Z, Marcovina, Santica M, Hughes, Steven G, Graham, Mark J, Crooke, Rosanne M et al. · 2016 · The Lancet
101. Association of an intensive lifestyle intervention with remission of type 2 diabetes
     Gregg, Edward W., Chen, Haiying, Wagenknecht, Lynne E., Clark, Jeanne M., Delahanty, Linda M., Bantle, John, Pownall, Henry J., Johnson, Karen C., Safford, Monika M., Kitabchi, Abbas E. et al. · 2012 · JAMA
102. Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
     DeFronzo, Ralph A., Tripathy, Devjit, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Henry, Robert R., Hodis, Howard N., Kitabchi, Abbas E. et al. · 2011 · New England Journal of Medicine
103. Hypoglycemia in the Diabetes Control and Complications Trial
     The Diabetes Control and Complications Trial Research Group · 1997 · Diabetes
104. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
     Sorli, Christopher, Harashima, Shin-ichi, Tsoukas, George M, Unger, Jeffrey, Karsbøl, Julie Derving, Hansen, Thomas, Bain, Stephen C · 2017 · The Lancet Diabetes &amp; Endocrinology
105. Distal symmetric polyneuropathy: A definition for clinical research: Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
     England, J. D., Gronseth, G. S., Franklin, G., Miller, R. G., Asbury, A. K., Carter, G. T., Cohen, J. A., Fisher, M. A., Howard, J. F., Kinsella, L. J. et al. · 2005 · Neurology
106. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery
     Frisch, Anna, Chandra, Prakash, Smiley, Dawn, Peng, Limin, Rizzo, Monica, Gatcliffe, Chelsea, Hudson, Megan, Mendoza, Jose, Johnson, Rachel, Lin, Erica et al. · 2010 · Diabetes Care
107. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
     2016 · The Lancet Diabetes &amp; Endocrinology
108. Glycemic variability: A strong independent predictor of mortality in critically ill patients.
     Krinsley, James S. · 2008 · Critical Care Medicine
109. Association of Triglyceride-Lowering <i>LPL</i> Variants and LDL-C–Lowering <i>LDLR</i> Variants With Risk of Coronary Heart Disease
     Ference, Brian A., Kastelein, John J. P., Ray, Kausik K., Ginsberg, Henry N., Chapman, M. John, Packard, Chris J., Laufs, Ulrich, Oliver-Williams, Clare, Wood, Angela M., Butterworth, Adam S. et al. · 2019 · JAMA
110. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)
     Umpierrez, Guillermo E., Smiley, Dawn, Jacobs, Sol, Peng, Limin, Temponi, Angel, Mulligan, Patrick, Umpierrez, Denise, Newton, Christopher, Olson, Darin, Rizzo, Monica · 2011 · Diabetes Care
111. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)
     Apovian, Caroline M., Aronne, Louis, Rubino, Domenica, Still, Christopher, Wyatt, Holly, Burns, Colleen, Kim, Dennis, Dunayevich, Eduardo, for the COR‐II Study Group · 2013 · Obesity
112. Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise
     Ele Ferrannini, Silvia Jimenez Ramos, Afshin Salsali, Weihua Tang, James F. List · 2010 · Diabetes Care
113. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study
     Garvey, W Timothy, Ryan, Donna H, Look, Michelle, Gadde, Kishore M, Allison, David B, Peterson, Craig A, Schwiers, Michael, Day, Wesley W, Bowden, Charles H · 2012 · The American Journal of Clinical Nutrition
114. Social determinants of health equity
     Marmot, Michael, Allen, Jessica J. · 2014 · American Journal of Public Health
115. Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP)
     Allison, David B., Gadde, Kishore M., Garvey, William Timothy, Peterson, Craig A., Schwiers, Michael L., Najarian, Thomas, Tam, Peter Y., Troupin, Barbara, Day, Wesley W. · 2012 · Obesity
116. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial
     Gardner, Christopher D., Trepanowski, John F., Del Gobbo, Liana C., Hauser, Michelle E., Rigdon, Joseph, Ioannidis, John P. A., Desai, Manisha, King, Abby C. · 2018 · JAMA
117. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
     Lind, Marcus, Polonsky, William, Hirsch, Irl B., Heise, Tim, Bolinder, Jan, Dahlqvist, Sofia, Schwarz, Erik, Ólafsdóttir, Arndís Finna, Frid, Anders, Wedel, Hans et al. · 2017 · JAMA
118. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial
     de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., Stehouwer, C. D. A. · 2010 · BMJ
119. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood
     Dabelea, Dana, Stafford, Jeanette M., Mayer-Davis, Elizabeth J., D’Agostino, Ralph, Dolan, Lawrence, Imperatore, Giuseppina, Linder, Barbara, Lawrence, Jean M., Marcovina, Santica M., Mottl, Amy K. et al. · 2017 · JAMA
120. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
     Holt, Richard I.G., DeVries, J. Hans, Hess-Fischl, Amy, Hirsch, Irl B., Kirkman, M. Sue, Klupa, Tomasz, Ludwig, Barbara, Nørgaard, Kirsten, Pettus, Jeremy, Renard, Eric et al. · 2021 · Diabetes Care
121. Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
     The ASCEND Study Collaborative Group · 2018 · New England Journal of Medicine
122. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications study
     Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., Ward, J. D. · 1996 · Diabetologia
123. Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the breast cancer association consortium studies
     Yang, Xiaohong R., Chang-Claude, Jenny, Goode, Ellen L., Couch, Fergus J., Nevanlinna, Heli, Milne, Roger L., Gaudet, Mia, Schmidt, Marjanka K., Broeks, Annegien, Cox, Angela et al. · 2011 · JNCI: Journal of the National Cancer Institute
124. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006
     Cowie, Catherine C., Rust, Keith F., Byrd-Holt, Danita D., Gregg, Edward W., Ford, Earl S., Geiss, Linda S., Bainbridge, Kathleen E., Fradkin, Judith E. · 2010 · Diabetes Care
125. Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria
     Sacks, David A., Hadden, David R., Maresh, Michael, Deerochanawong, Chaicharn, Dyer, Alan R., Metzger, Boyd E., Lowe, Lynn P., Coustan, Donald R., Hod, Moshe, Oats, Jeremy J.N. et al. · 2012 · Diabetes Care
126. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors
     Robyn L. McClelland, Neal W. Jorgensen, Matthew Jay Budoff, Michael Joseph Blaha, Wendy S. Post, Richard A. Kronmal, Diane E. Bild, Steven Shea, Kiang Liu, Karol E. Watson et al. · 2015 · Journal of the American College of Cardiology
127. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention study: A 23-year follow-up study
     Li, Guangwei, Zhang, Ping, Wang, Jinping, An, Yali, Gong, Qiuhong, Gregg, Edward W, Yang, Wenying, Zhang, Bo, Shuai, Ying, Hong, Jing et al. · 2014 · The Lancet Diabetes &amp; Endocrinology
128. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
     Mosenzon, Ofri, Wiviott, Stephen D, Cahn, Avivit, Rozenberg, Aliza, Yanuv, Ilan, Goodrich, Erica L, Murphy, Sabina A, Heerspink, Hiddo J L, Zelniker, Thomas A, Dwyer, Jamie P et al. · 2019 · The Lancet Diabetes &amp; Endocrinology
129. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
     HPS2-THRIVE Collaborative Group, Haynes, R., Jiang, L., Hopewell, J. C., Li, J., Chen, F., Parish, S., Landray, M. J., Collins, R., Armitage, J. et al. · 2013 · European Heart Journal
130. Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
     Bjerre Knudsen, Lotte, Madsen, Lars Wichmann, Andersen, Søren, Almholt, Kasper, de Boer, Anne S., Drucker, Daniel J., Gotfredsen, Carsten, Egerod, Frederikke Lihme, Hegelund, Anne Charlotte, Jacobsen, Helene et al. · 2010 · Endocrinology
131. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials
     Franz, Marion J., Boucher, Jackie L., Rutten-Ramos, Stephanie, VanWormer, Jeffrey J. · 2015 · Journal of the Academy of Nutrition and Dietetics
132. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)
     Umpierrez, Guillermo E., Smiley, Dawn, Zisman, Ariel, Prieto, Luz M., Palacio, Andres, Ceron, Miguel, Puig, Alvaro, Mejia, Roberto · 2007 · Diabetes Care
133. Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
     Unger, Roger H., Cherrington, Alan D. · 2012 · Journal of Clinical Investigation
134. Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?
     Haffner, Steven M. · 1990 · JAMA
135. Three-year efficacy of complex insulin regimens in type 2 diabetes
     Holman, Rury R., Farmer, Andrew J., Davies, Melanie J., Levy, Jonathan C., Darbyshire, Julie L., Keenan, Joanne F., Paul, Sanjoy K. · 2009 · New England Journal of Medicine
136. Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes
     Kosiborod, Mikhail, Rathore, Saif S., Inzucchi, Silvio E., Masoudi, Frederick A., Wang, Yongfei, Havranek, Edward P., Krumholz, Harlan M. · 2005 · Circulation
137. Postprandial versus Preprandial Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus Requiring Insulin Therapy
     de Veciana, Margarita, Major, Carol A., Morgan, Mark A., Asrat, Tamerou, Toohey, Julianne S., Lien, Jean M., Evans, Arthur T. · 1995 · New England Journal of Medicine
138. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk
     Sniderman, Allan D., Williams, Ken, Contois, John H., Monroe, Howard M., McQueen, Matthew J., de Graaf, Jacqueline, Furberg, Curt D. · 2011 · Circulation: Cardiovascular Quality and Outcomes
139. Untitled work
     Colberg · 2010 · 10.2337/dc10-1548
140. Fetuses of obese mothers develop insulin resistance in utero
     Catalano, Patrick M., Presley, Larraine, Minium, Judi, Hauguel-de Mouzon, Sylvie · 2009 · Diabetes Care
141. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study
     Hollander, Priscilla A, Elbein, Steven C, Hirsch, Irl B, Kelley, David, McGill, Janet, Taylor, Terry, Weiss, Stuart R, Crockett, Samuel E, Kaplan, Roy A, Comstock, John et al. · 1998 · Diabetes Care
142. Prevention of Diabetes With Mediterranean Diets: A Subgroup Analysis of a Randomized Trial
     Salas-Salvadó, Jordi, Bulló, Mònica, Estruch, Ramón, Ros, Emilio, Covas, Maria-Isabel, Ibarrola-Jurado, Núria, Corella, Dolores, Arós, Fernando, Gómez-Gracia, Enrique, Ruiz-Gutiérrez, Valentina et al. · 2014 · Annals of Internal Medicine
143. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
     Tuttle, Katherine R, Lakshmanan, Mark C, Rayner, Brian, Busch, Robert S, Zimmermann, Alan G, Woodward, D Bradley, Botros, Fady T · 2018 · The Lancet Diabetes &amp; Endocrinology
144. Sleep is essential to health: an American Academy of Sleep Medicine position statement
     Ramar, Kannan, Malhotra, Raman K., Carden, Kelly A., Martin, Jennifer L., Abbasi-Feinberg, Fariha, Aurora, R. Nisha, Kapur, Vishesh K., Olson, Eric J., Rosen, Carol L., Rowley, James A. et al. · 2021 · Journal of Clinical Sleep Medicine
145. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes
     Tonstad, Serena, Butler, Terry, Yan, Ru, Fraser, Gary E. · 2009 · Diabetes Care
146. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
     1984 · JAMA
147. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
     Hegele, Robert A, Ginsberg, Henry N, Chapman, M John, Nordestgaard, Børge G, Kuivenhoven, Jan Albert, Averna, Maurizio, Borén, Jan, Bruckert, Eric, Catapano, Alberico L, Descamps, Olivier S et al. · 2014 · The Lancet Diabetes &amp; Endocrinology
148. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
     Vallon, Volker, Thomson, Scott C. · 2017 · Diabetologia
149. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
     Beck, Roy W., Riddlesworth, Tonya D., Ruedy, Katrina, Ahmann, Andrew, Haller, Stacie, Kruger, Davida, McGill, Janet B., Polonsky, William, Price, David, Aronoff, Stephen et al. · 2017 · Annals of Internal Medicine
150. Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
     Bril, V., England, J., Franklin, G.M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D.J., Perkins, B., Russell, J.W. et al. · 2011 · Neurology
151. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
     Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo E. Umpierrez, Robert S. Zimmerman, Timothy Silleck Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel E. Dagogo-Jack et al. · 2015 · Endocrine Practice
152. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials
     Neuhouser, Marian L., Aragaki, Aaron K., Prentice, Ross L., Manson, JoAnn E., Chlebowski, Rowan, Carty, Cara L., Ochs-Balcom, Heather M., Thomson, Cynthia A., Caan, Bette J., Tinker, Lesley F. et al. · 2015 · JAMA Oncology
153. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes
     Hermansen, Kjeld, Davies, Melanie, Derezinski, Taudeusz, Martinez Ravn, Gabrielle, Clauson, Per, Home, Philip, on behalf of the Levemir Treat-to-Target Study Group · 2006 · Diabetes Care
154. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial
     Haak, Thomas, Hanaire, Hélène, Ajjan, Ramzi, Hermanns, Norbert, Riveline, Jean-Pierre, Rayman, Gerry · 2017 · Diabetes Therapy
155. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: A multicenter randomized trial
     Nassif, Michael E., Windsor, Sheryl L., Borlaug, Barry A., Kitzman, Dalane W., Shah, Sanjiv J., Tang, Fengming, Khariton, Yevgeniy, Malik, Ali O., Khumri, Taiyeb, Umpierrez, Guillermo et al. · 2021 · Nature Medicine
156. Prognostic Value of Ambulatory Blood Pressure
     Paolo Verdecchia · 2000 · Hypertension
157. Physical Activity in the Prevention of Type 2 Diabetes
     Laaksonen, David E., Lindström, Jaana, Lakka, Timo A., Eriksson, Johan G., Niskanen, Leo, Wikström, Katja, Aunola, Sirkka, Keinänen-Kiukaanniemi, Sirkka, Laakso, Mauri, Valle, Timo T. et al. · 2005 · Diabetes
158. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
     Kaj Stenlöf, William T. Cefalu, Kyung‐Ah Kim, Maria Alba, Keith Usiskin, C. Tong, William J. Canovatchel, Gary E. Meininger · 2012 · Diabetes Obesity and Metabolism
159. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study
     Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., Sawicki, P. T. · 2009 · Diabetologia
160. Diet quality as assessed by the Healthy Eating Index, Alternate Healthy Eating Index, Dietary Approaches to Stop Hypertension score, and health outcomes: an updated systematic review and meta-analysis of cohort studies
     Schwingshackl, Lukas, Bogensberger, Berit, Hoffmann, Georg · 2018 · Journal of the Academy of Nutrition and Dietetics
161. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus
     Haddad, E., Wells, G. A., Sigal, R. J., Boul�, N. G., Kenny, G. P. · 2003 · Diabetologia
162. Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies ,
     Schwingshackl, Lukas, Schwedhelm, Carolina, Hoffmann, Georg, Lampousi, Anna-Maria, Knüppel, Sven, Iqbal, Khalid, Bechthold, Angela, Schlesinger, Sabrina, Boeing, Heiner · 2017 · The American Journal of Clinical Nutrition
163. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
     Bethel, M Angelyn, Patel, Rishi A, Merrill, Peter, Lokhnygina, Yuliya, Buse, John B, Mentz, Robert J, Pagidipati, Neha J, Chan, Juliana C, Gustavson, Stephanie M, Iqbal, Nayyar et al. · 2018 · The Lancet Diabetes &amp; Endocrinology
164. Importance of Perioperative Glycemic Control in General Surgery: A Report From the Surgical Care and Outcomes Assessment Program
     Kwon, Steve, Thompson, Rachel, Dellinger, Patchen, Yanez, David, Farrohki, Ellen, Flum, David · 2013 · Annals of Surgery
165. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
     Garber, Alan J., Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bush, Michael A., DeFronzo, Ralph A., Garber, Jeffrey R. et al. · 2020 · Endocrine Practice
166. Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
     Ahmann, Andrew J., Capehorn, Matthew, Charpentier, Guillaume, Dotta, Francesco, Henkel, Elena, Lingvay, Ildiko, Holst, Anders G., Annett, Miriam P., Aroda, Vanita R. · 2018 · Diabetes Care
167. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
     Pratley, Richard, Amod, Aslam, Hoff, Søren Tetens, Kadowaki, Takashi, Lingvay, Ildiko, Nauck, Michael, Pedersen, Karen Boje, Saugstrup, Trine, Meier, Juris J · 2019 · The Lancet
168. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review
     Sniderman, Allan D., Thanassoulis, George, Glavinovic, Tamara, Navar, Ann Marie, Pencina, Michael, Catapano, Alberico, Ference, Brian A. · 2019 · JAMA Cardiology
169. Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors
     Stamatouli, Angeliki M., Quandt, Zoe, Perdigoto, Ana Luisa, Clark, Pamela L., Kluger, Harriet, Weiss, Sarah A., Gettinger, Scott, Sznol, Mario, Young, Arabella, Rushakoff, Robert et al. · 2018 · Diabetes
170. The effects of high-intensity interval training on glucose regulation and insulin resistance: A meta-analysis
     Jelleyman, C., Yates, T., O'Donovan, G., Gray, L. J., King, J. A., Khunti, K., Davies, M. J. · 2015 · Obesity Reviews
171. Lifestyle intervention for pre-diabetic neuropathy
     Smith, A. Gordon, Russell, James, Feldman, Eva L., Goldstein, Jonathan, Peltier, Amanda, Smith, Sheldon, Hamwi, Jouhaina, Pollari, Donald, Bixby, Billie, Howard, James et al. · 2006 · Diabetes Care
172. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes
     Garg, Satish K., Weinzimer, Stuart A., Tamborlane, William V., Buckingham, Bruce A., Bode, Bruce W., Bailey, Timothy S., Brazg, Ronald L., Ilany, Jacob, Slover, Robert H., Anderson, Stacey M. et al. · 2017 · Diabetes Technology &amp; Therapeutics
173. Anti-müllerian hormone and ovarian reserve: Update on assessing ovarian function
     Moolhuijsen, Loes M E, Visser, Jenny A · 2020 · The Journal of Clinical Endocrinology &amp; Metabolism
174. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
     on behalf of the SCALE study group, Blackman, A, Foster, G D, Zammit, G, Rosenberg, R, Aronne, L, Wadden, T, Claudius, B, Jensen, C B, Mignot, E · 2016 · International Journal of Obesity
175. Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
     Knowler, William C., Pettitt, David J., Saad, Mohammed F., Bennett, Peter H. · 1990 · Diabetes/Metabolism Reviews
176. Longitudinal impact of sleep on overweight and obesity in children and adolescents: A systematic review and bias-adjusted meta-analysis
     Fatima, Y., Doi, S. A. R., Mamun, A. A. · 2015 · Obesity Reviews
177. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
     Mingrone, Geltrude, Panunzi, Simona, De Gaetano, Andrea, Guidone, Caterina, Iaconelli, Amerigo, Capristo, Esmeralda, Chamseddine, Ghassan, Bornstein, Stefan R, Rubino, Francesco · 2021 · The Lancet
178. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis
     Falciglia, Mercedes, Freyberg, Ron W., Almenoff, Peter L., D’Alessio, David A., Render, Marta L. · 2009 · Critical Care Medicine
179. Efficacy and safety of degludec versus glargine in type 2 diabetes.
     Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pieber, Thomas R., Pratley, Richard E., Haahr, Poul-Martin, Lange, Martin, Brown-Frandsen, Kirstine et al. · 2017 · New England Journal of Medicine
180. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism
     Lowe, William L., Scholtens, Denise M., Kuang, Alan, Linder, Barbara, Lawrence, Jean M., Lebenthal, Yael, McCance, David, Hamilton, Jill, Nodzenski, Michael, Talbot, Octavious et al. · 2019 · Diabetes Care
181. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
     Pierre Amarenco, Kim Js, Julien Labreuche, Hugo Charles, Jérémie Abtan, Yannick Béjot, Lucie Cabrejo, Cha Jk, Grégory Ducrocq, Maurice Giroud et al. · 2019 · New England Journal of Medicine
182. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses
     Reynolds, Andrew N., Akerman, Ashley P., Mann, Jim · 2020 · PLOS Medicine
183. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
     Umpierrez, Guillermo, Korytkowski, Mary · 2016 · Nature Reviews Endocrinology
184. Gabapentin for chronic neuropathic pain in adults
     Wiffen, Philip J, Derry, Sheena, Bell, Rae Frances, Rice, Andrew SC, Tölle, Thomas Rudolf, Phillips, Tudor, Moore, R Andrew · 2017 · Cochrane Database of Systematic Reviews
185. American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
     Handelsman, Yehuda, Bloomgarden, Zachary T., Grunberger, George, Umpierrez, Guillermo, Zimmerman, Robert S., Bailey, Timothy S., Blonde, Lawrence, Bray, George A., Cohen, A. Jay, Dagogo-Jack, Samuel et al. · 2015 · Endocrine Practice
186. Weight loss with naltrexone sr/bupropion sr combination therapy as an adjunct to behavior modification: the COR-BMOD trial
     Wadden, Thomas A., Foreyt, John P., Foster, Gary D., Hill, James O., Klein, Samuel, O'Neil, Patrick M., Perri, Michael G., Pi‐Sunyer, F. Xavier, Rock, Cheryl L., Erickson, Janelle S. et al. · 2011 · Obesity
187. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care
     Hod, Moshe, Kapur, Anil, Sacks, David A., Hadar, Eran, Agarwal, Mukesh, Di Renzo, Gian Carlo, Roura, Luis Cabero, McIntyre, Harold David, Morris, Jessica L., Divakar, Hema · 2015 · International Journal of Gynecology &amp; Obstetrics
188. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
     Wheeler, David C, Stefánsson, Bergur V, Jongs, Niels, Chertow, Glenn M, Greene, Tom, Hou, Fan Fan, McMurray, John J V, Correa-Rotter, Ricardo, Rossing, Peter, Toto, Robert D et al. · 2021 · The Lancet Diabetes &amp; Endocrinology
189. Sulfonylurea Inadequacy
     Alex D. Wright, Andrew C Burden, Richard Paisey, Carole A. Cull, Rury R. Holman, for the U.K. Prospective Diabetes Study Group · 2002 · Diabetes Care
190. Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome
     Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony, on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators · 2009 · Diabetes Care
191. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes
     Knopp, Robert H., d’Emden, Michael, Smilde, Johan G., Pocock, Stuart J., on behalf of the ASPEN Study Group · 2006 · Diabetes Care
192. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
     Martens, Thomas, Beck, Roy W., Bailey, Ryan, Ruedy, Katrina J., Calhoun, Peter, Peters, Anne L., Pop-Busui, Rodica, Philis-Tsimikas, Athena, Bao, Shichun, Umpierrez, Guillermo et al. · 2021 · JAMA
193. The obese adipose tissue microenvironment in cancer development and progression
     Quail, Daniela F., Dannenberg, Andrew J. · 2019 · Nature Reviews Endocrinology
194. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
     Pop-Busui, Rodica, Evans, Gregory W., Gerstein, Hertzel C., Fonseca, Vivian, Fleg, Jerome L., Hoogwerf, Byron J., Genuth, Saul, Grimm, Richard H., Corson, Marshall A., Prineas, Ronald et al. · 2010 · Diabetes Care
195. Increased mortality of patients with diabetes reporting severe hypoglycemia
     McCoy, Rozalina G., Van Houten, Holly K., Ziegenfuss, Jeanette Y., Shah, Nilay D., Wermers, Robert A., Smith, Steven A. · 2012 · Diabetes Care
196. Dietary approaches to stop hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials
     Filippou, Christina D, Tsioufis, Costas P, Thomopoulos, Costas G, Mihas, Costas C, Dimitriadis, Kyriakos S, Sotiropoulou, Lida I, Chrysochoou, Christina A, Nihoyannopoulos, Petros I, Tousoulis, Dimitrios M · 2020 · Advances in Nutrition
197. A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes&lt;subtitle&gt;The Sleep AHEAD Study&lt;/subtitle&gt;&lt;alt-title&gt;Effect of Weight Loss on Obstructive Sleep Apnea&lt;/alt-title&gt;
     Foster, Gary D. · 2009 · Archives of Internal Medicine
198. Rosiglitazone-Associated Fractures in Type 2 Diabetes
     Kahn, Steven E., Zinman, Bernard, Lachin, John M., Haffner, Steven M., Herman, William H., Holman, Rury R., Kravitz, Barbara G., Yu, Dahong, Heise, Mark A., Aftring, R. Paul et al. · 2008 · Diabetes Care
199. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study
     Aroda, Vanita R., Edelstein, Sharon L., Goldberg, Ronald B., Knowler, William C., Marcovina, Santica M., Orchard, Trevor J., Bray, George A., Schade, David S., Temprosa, Marinella G., White, Neil H. et al. · 2016 · The Journal of Clinical Endocrinology &amp; Metabolism
200. Congenital susceptibility to NIDDM. Role of intrauterine environment
     Pettitt, David J, Aleck, Kirk A, Baird, H Robert, Carraher, Michael J, Bennett, Peter H, Knowler, William C · 1988 · Diabetes